Friday, August 29, 2014 12:29:14 AM
The Problem: There's a disease that causes people's toes to fall off. Clinicians have determined that the cause of the toe loss is a DNA mutation. The DNA codes for a faulty protein that cuts off blood supply to the toes, causing them to die and fall off.
Company A: Company A makes a daily dose pill that when eaten, causes the bad protein to misfold and be destroyed. They patent the pill.
Company B: Company B discovers that extreme heat will cause the protein to break apart. They market heated socks, and toes stay attached. They patent the sock.
Both Company A and B came up with a solution to the problem of toe loss. Neither one would be protected by a patent because the mechanism of the treatments are completely non-overlapping. You can't blanketly patent "Stopping toes from falling off" the same way KBLB can't patent "putting spider DNA into silkworms".
Spider DNA of various sources can get into silkworms through numerous mechanisms, only one or two of which KBLB has patented. KBLB picked their path, and hopefully it holds up long enough to get to market. Nobody is showing strong competition now, but that's the nature of technological innovation. A discovery tomorrow in the lab, combined with more textiles knowledge than KBLB started with (let alone one of the other companies that already exists getting better science) could put KBLB at risk.
Is KBLB in the lead right now? Possibly/Probably depending on your world outlook. Are they guaranteed first to market? Absolutely not. That's not bashing, that's reality until they make a marketable product.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM